Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

BOTOX® Treatment in Pediatric Lower Limb Spasticity

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Allergan
Sponsor:
Information provided by (Responsible Party):
Allergan
ClinicalTrials.gov Identifier:
NCT01603628
First received: May 21, 2012
Last updated: September 22, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2017
  Estimated Primary Completion Date: April 2017 (Final data collection date for primary outcome measure)